The Fes tyrosine kinase: A signal transducer that regulates myeloid-specific gene expression through transcriptional activation

Blood Cells, Molecules, and Diseases

Volumn 32, Issue 2, 2004, Pages 302-308

  Kim, Jynho ^a   Ogata, Yoshiyasu ^a   Ali, Humayra ^a   Feldman, Ricardo A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Fes tyrosine kinase; Myeloid specific gene expression; Transcriptional activation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; GENE PRODUCT; PROTEIN KINASE FES; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; GENE EXPRESSION REGULATION; GRANULOCYTE; HUMAN; MACROPHAGE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ENZYME ACTIVATION; FUSION PROTEINS, GAG-ONC; GENE EXPRESSION REGULATION; GRANULOCYTES; HUMANS; MOLECULAR MIMICRY; MONOCYTES; MYELOID CELLS; MYELOPOIESIS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; U937 CELLS;

EID: 1542360771     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2003.12.004     Document Type: Article

References (40)

1. Clarke S., Gordon S. Myeloid-specific gene expression. J. Leukocyte Biol. 63:1998;153-168.
2. Metcalf D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science. 254:1991;529-533.
3. Valledor A.F., Borras F.E., Cullell-Young M., Celada A. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukocyte Biol. 63:1998;405-417.
4. fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J. Biol. Chem. 271:1996;3562-3567.
5. Corey S., Eguinoa A., Puyana-Theall K., Bolen J.B., Cantley L., Mollinedo F., Jackson T.R., Hawkins P.T., Stephens L.R. Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells. EMBO J. 12:1993;2681-2690.
6. Hanazono Y., Chiba S., Sasaki K., Mano H., Miyajima A., Arai K., Yazaki Y., Hirai H. c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J. 12:1993;1641-1646.
7. Jücker M., Feldman R.A. Identification of a new adapter protein that may link the common beta subunit of the receptor for granulocyte/ macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase. J. Biol. Chem. 270:1995;27817-27822.
8. Park W.Y., Ahn J.H., Feldman R.A., Seo J.S. c-Fes tyrosine kinase binds to and activates STAT3 after granulocyte-macrophage colony-stimulating factor stimulation. Cancer Lett. 129:1998;29-37.
9. Quelle F.W., Sato N., Witthuhn B.A., Inhorn R.C., Eder M., Miyajima A., Griffin J.D., Ihle J.N. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14:1994;4335-4341.
10. Torigoe T., O'Connor R., Santoli D., Reed J.C. Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines. Blood. 80:1992;617-624.
11. Henkel G.W., McKercher S.R., Yamamoto H., Anderson K.L., Oshima R.G., Maki R.A. PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells. Blood. 88:1996;2917-2926.
12. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
13. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
14. Smith L.T., Hohaus S., Gonzalez D.A., Dziennis S.E., Tenen D.G. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 88:1996;1234-1247.
15. Zhang D.E., Zhang P., Wang N.D., Hetherington C.J., Darlington G.J., Tenen D.G. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94:1997;569-574.
16. McLemore M.L., Grewal S., Liu F., Archambault A., Poursine-Laurent J., Haug J., Link D.C. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity. 14:2001;193-204.
17. Shimozaki K., Nakajima K., Hirano T., Nagata S. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem. 272:1997;25184-25189.
18. Wen Z., Zhong Z., Darnell J.E. Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
19. Zhong Z., Wen Z., Darnell J.E. Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 264:1994;95-98.
20. Lodie T.A., Savedra R., Golenbock D.T., Van Beveren C.P., Maki R.A., Fenton M.J. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158:1997;1848-1856.
21. Pongubala J.M., Van Beveren C., Nagulapalli S., Klemsz M.J., McKercher S.R., Maki R.A., Atchison M.L. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science. 259:1993;1622-1625.
22. Rieske P., Pongubala J.M. AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J. Biol. Chem. 276:2001;8460-8468.
23. Behre G., Singh S.M., Liu H., Bortolin L.T., Christopeit M., Radomska H.S., Rangatia J., Hiddemann W., Friedman A.D., Tenen D.G. Ras signaling enhances the activity of C/EBPalpha to induce granulocytic differentiation by phosphorylation of serine 248. J. Biol. Chem. 277:2002;26293-26299.
24. Feldman R.A., Gabrilove J.L., Tam J.P., Moore M.A., Hanafusa H. Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 82:1985;2379-2383.
25. Feldman R.A., Vass W.C., Tambourin P.E. Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential. Oncog. Res. 1:1987;441-458.
26. Hanafusa H. The fps/fes oncogene. Reddy E.P., Skalka A.M., Curran T. The Oncogene Handbook. 1988;39-57 Elsevier, Amsterdam.
27. Greer P., Haigh J., Mbamalu G., Khoo W., Bernstein A., Pawson T. The fps/fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol. Cell. Biol. 14:1994;6755-6763.
28. MacDonald I., Levy J., Pawson T. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol. Cell. Biol. 5:1985;2543-2551.
29. Samarut J., Mathey-Prevot B., Hanafusa H. Preferential expression of the c-fps protein in chicken macrophages and granulocytic cells. Mol. Cell. Biol. 5:1985;1067-1072.
30. -/- mice. Immunity. 13:2000;397-407.
31. Kim J., Feldman R.A. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol. Cell. Biol. 22:2002;1903-1918.
32. bcr/abl-transduced bone marrow. Blood. 92:1998;3780-3792.
33. Heydemann A., Boehmler J.H., Simon M.C. Expression of two myeloid cell-specific genes requires the novel transcription factor, c-fes expression factor. J. Biol. Chem. 272:1997;29527-29537.
34. Heydemann A., Juang G., Hennessy K., Parmacek M.S., Simon M.C. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol. Cell. Biol. 16:1996;1676-1686.
35. Rovera G., Valtieri M., Mavilio F., Reddy E.P. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene. 1:1987;29-35.
36. Valtieri M., Tweardy D.J., Caracciolo D., Johnson K., Mavilio F., Altmann S., Santoli D., Rovera G. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J. Immunol. 138:1987;3829-3835.
37. Kim J., Ogata Y., Ali H., Feldman R.A. Fes tyrosine kinase promotes survival and terminal granulocyte differentiation of factor-dependent myeloid progenitors (32D) and activates lineage-specific transcription factors. J. Biol. Chem. 278:2003;14978-14984.
38. Cleveland J.L., Dean M., Rosenberg N., Wang J.Y., Rapp U.R. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell. Biol. 9:1989;5685-5695.
39. Cortez D., Reuther G., Pendergast A.M. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells. Oncogene. 15:1997;2333-2342.
40. Kruger A., Anderson S.M. The v-src oncogene blocks the differentiation of a murine myeloid progenitor cell line and induces a tumorigenic phenotype. Oncogene. 6:1991;245-256.